Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-35 (IGHV3-35) is a probable non-functional open reading frame within the immunoglobulin heavy chain variable region locus, situated on chromosome 14q32.33. The IGHV3-35 gene segment encodes a variable domain that normally helps form the antigen binding site of immunoglobulins (antibodies); however, due to mutations, recombination defects, and/or conserved amino acid changes, IGHV3-35 is generally predicted to be non-functional and does not contribute to the synthesis of productive immunoglobulin heavy chains. Immunoglobulin heavy variable genes collectively enable the generation of antibody diversity via V-(D)-J recombination and somatic hypermutation, forming critical components of the adaptive immune response. IGHV allelic variation influences the structure and function of the antibody repertoire in the population, but the IGHV3-35 locus is typically absent or non-expressed in most individuals, so it does not participate in functional immune processes nor present as a drug target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-35 (IGHV3-35).